Liam is an early career clinical researcher whose PhD was awarded in June 2024. Their current research focuses on marginalised populations and their clinical outcomes including interventions to address methamphetamine use disorder through clinical trials of pharmacotherapies (lisdexamfetamine, psilocybin, naltrexone-bupropion, ketamine) and a smartphone application.
Liam works on a broad range of clinical research projects with mixed-methods techniques, and has started an independent program of research investigating the intersection of sleep and substance use.